You are here

Article info

Article menu

Download PDFPDF

XML
Recent advances in clinical practice
Drug-induced liver injury: recent advances in diagnosis and risk assessment

Authors

  • Gerd A Kullak-Ublick Department of Clinical Pharmacology and Toxicology, University Hospital Zurich and University of Zurich, Zurich, Switzerland Drug Safety and Epidemiology, Novartis Pharma, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Raul J Andrade Unidad de Gestión Clínica de Aparato Digestivo, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Málaga, Spain PubMed articlesGoogle scholar articles
  • Michael Merz Novartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Peter End Novartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Andreas Benesic Department of Medicine II, Klinikum Grosshadern of the University of Munich (KUM), University of Munich, Munich, Germany MetaHeps GmbH, Planegg/Martinsried, Germany PubMed articlesGoogle scholar articles
  • Alexander L Gerbes Department of Medicine II, Klinikum Grosshadern of the University of Munich (KUM), University of Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • Guruprasad P Aithal National Institute for Health Research (NIHR), Nottingham Digestive Diseases Biomedical Research Unit, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Gerd A Kullak-Ublick, Department of Clinical Pharmacology and Toxicology, University Hospital Zurich and University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; gerd.kullak{at}usz.ch
View Full Text

Citation

Kullak-Ublick GA, Andrade RJ, Merz M, et al
Drug-induced liver injury: recent advances in diagnosis and risk assessment
Gut 2017;66:1154-1164.

Publication history

  • Received November 8, 2016
  • Revised February 24, 2017
  • Accepted February 28, 2017
  • First published March 23, 2017.
Online issue publication 
October 26, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/